ALK fusion in a cohort of 469 Finnish patients with non-small cell lung cancer

被引:0
|
作者
Merkkiniemi, K. [1 ]
Kero, M. [2 ]
Maki-Nevala, S. [1 ]
Sarhadi, V. K. [1 ]
Tikkanen, M. [1 ]
Wirtanen, T. [1 ]
Ronty, M. [2 ]
Knuuttila, A. [3 ]
Knuutila, S. [1 ]
机构
[1] Haartman Inst, Dept Pathol, Helsinki, Finland
[2] HUSLAB Helsinki Univ, Cent Hosp, Dept Pathol, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Heart & Lung Ctr, Dept Pulm Med, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
672
引用
收藏
页码:S161 / S161
页数:1
相关论文
共 50 条
  • [41] Concurrent Genomic Alterations in ALK-Rearranged Non-Small Cell Lung Cancer Patients
    Clave, S.
    Salido, M.
    Gibert, J.
    Hardy-Werbin, M.
    Weingartner, E.
    Hernandez, J.
    Nichol, D.
    Rocha, P.
    Riera, X.
    Blanco, R.
    Bosch-Barrera, J.
    Taus, A.
    Pijuan, L.
    Bellosillo, B.
    Arriola, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S508 - S509
  • [42] Exploration of ALK Fused Gene Expression in Non-Small Cell Lung Cancer Patients by Immunohistochemistry
    Cao, Jie L.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S780 - S780
  • [43] Clinical effect of alectinib in patients with ALK-positive non-small cell lung cancer
    Nishi, Koichi
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer Patients
    Miyazaki, Kunihiko
    Sato, Shinya
    Kodama, Takahide
    Numata, Takeshi
    Endo, Takeo
    Yamamoto, Yusuke
    Shimizu, Kei
    Yamada, Hideyasu
    Hayashihara, Kenji
    Okauchi, Shinichiro
    Satoh, Hiroaki
    Yamada, Yutaka
    Tamura, Tomohiro
    Saito, Kazuto
    Kikuchi, Norihiro
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Watanabe, Hiroko
    Shiozawa, Toshihiro
    Hizawa, Nobuyuki
    Funayama, Yasunori
    Hayashi, Shigen
    Nakamura, Hiroyuki
    Yamashita, Takaaki
    IN VIVO, 2020, 34 (04): : 2001 - 2007
  • [45] Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer
    Doebele, Robert C.
    Pilling, Amanda B.
    Aisner, Dara L.
    Kutateladze, Tatiana G.
    Le, Anh T.
    Weickhardt, Andrew J.
    Kondo, Kimi L.
    Linderman, Derek J.
    Heasley, Lynn E.
    Franklin, Wilbur A.
    Varella-Garcia, Marileila
    Camidge, D. Ross
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1472 - 1482
  • [46] FREQUENCY OF ALK REARRANGEMENTS IN NON-SMALL CELL LUNG CANCER PATIENTS IN CHO RAY HOSPITAL
    Ngoc Minh Duong
    Vu Thuong Le
    Thong Vu Dang
    Ngoc Van Tran
    RESPIROLOGY, 2019, 24 : 188 - 188
  • [47] Pathological features of ALK mutations in Malaysian non-small cell lung cancer (NSCLC) patients
    Ariffin, R. B.
    Daud, K. A. B.
    Muttalif, A. R. B. Abdul
    Marzuki, N. B. Mohd
    ANNALS OF ONCOLOGY, 2015, 26 : 10 - 10
  • [48] Assessment of ALK Status by FISH on 1000 Spanish Non-Small Cell Lung Cancer Patients
    Vidal, Joana
    Clave, Sergi
    de Muga, Silvia
    Gonzalez, Iria
    Pijuan, Lara
    Gimeno, Javier
    Remon, Jordi
    Reguart, Noemi
    Vinolas, Nuria
    Girones, Regina
    Bernet, Laia
    Majem, Margarita
    Bosch-Barrera, Joaquim
    Porta, Rut
    Alonso, Nieves
    Palmero, Ramon
    Taus, Alvaro
    Albanell, Joan
    Espinet, Blanca
    Salido, Marta
    Arriola, Edurne
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (12) : 1816 - 1820
  • [49] Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients
    Passaro, A.
    Prelaj, A.
    Pochesci, A.
    Spitaleri, G.
    Rossi, G.
    Del Signore, E.
    Catania, C.
    de Marinis, F.
    DRUGS OF TODAY, 2017, 53 (08) : 435 - 446
  • [50] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511